Editas Medicine, Inc. (NASDAQ: EDIT) today announced the appointment of Jessica Hopfield, Ph.D., to its Board of Directors, effective immediately ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Management Changes Management Comments

Editas Medicine Names Jessica Hopfield, Ph.D., to Board of DirectorsFebruary 16, 2018 9:00 AM Viking Global's 13F Shows New Stake in Time Warner (TWX), Netease (NTES), PACCAR (PCAR), Exits Deere (DE) (more...)February 14, 2018 3:22 PM